Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMaven I&g Vct5 Regulatory News (MIG5)

Share Price Information for Maven I&g Vct5 (MIG5)

Share Price is delayed by 15 minutes
Get Live Data
28.80    0.00 (0.00%)
Bid:
27.80
Ask:
29.80
Spread: 2.00 (7.194%)
Market Cap: £76.28m
MIG5 Live PriceLast checked at - London Stock Exchange

Intraday Maven I&g Vct5 Share Chart

Offer for Subscription - Fully Subscribed

27 Mar 2026 17:07

RNS Number : 5159Y
Maven Income and Growth VCT 5 PLC
27 March 2026
 

Maven Income and Growth VCT 5 PLC

(the Company)

 

 

Offer for Subscription

 

 

On 2 October 2025, the Company and Maven Income and Growth VCT PLC, Maven Income and Growth VCT 3 PLC and Maven Income and Growth VCT 4 PLC announced the publication of a joint Prospectus in relation to offers for subscription of new ordinary shares of 10p each (together the "Offers" and each an "Offer").

 

The Board of the Company is pleased to announce that it has received applications up to its fundraising limit of £12.5 million (which includes the full utilisation of its £5 million over-allotment facility). On the basis that such applications received by the Company are all valid and accepted, the Offer of the Company is now fully subscribed and has now closed to further applications.

 

The Board of the Company intends that the final allotment in respect of applications for the 2025/2026 tax year will take place on 2 April 2026. Allotments in respect of the 2026/2027 tax year will take place on or before 30 April.

 

The Offers in relation to Maven Income and Growth VCT PLC, Maven Income and Growth VCT 3 PLC and Maven Income and Growth VCT 4 PLC remain open for applications and are expected to close to 2025/26 tax year applications on 2 April 2026 (unless fully subscribed by an earlier date), and to 2026/27 tax year applications on 24 April 2026.

 

Downloadable versions of the Prospectus documents are available at www.mavencp.com/vctoffer

 

Any enquiries in respect of the Offers, or requests for copies of the Prospectus documents (available free of charge), should be directed to:

 

 

Maven Capital Partners UK LLP

Kintyre House

205 West George Street

Glasgow

G2 2LW

 

Telephone: 0141 306 7400

E-mail: enquiries@mavencp.com

Maven Capital Partners UK LLPSecretary

27 March 2026

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCPPUAUWUPQGMM
Date   Source Headline
27th Feb 20203:04 pmRNSTransaction in Own Shares
24th Feb 20203:55 pmRNSTransaction in Own Shares
19th Feb 20204:30 pmRNSTransaction in Own Shares
18th Feb 202011:35 amRNSNet Asset Value and Proposed Final Dividend
28th Jan 20204:53 pmRNSDirectorate Change and Appointment of New Chairman
4th Dec 20199:45 amRNSStatement re Share Premium Account Cancellation
28th Nov 20192:06 pmRNSTransaction in Own Shares
7th Oct 20194:22 pmRNSTransaction in Own Shares
3rd Oct 20192:34 pmRNSNet Asset Value(s)
2nd Sep 20193:30 pmRNSDirector/PDMR Shareholding
2nd Sep 20193:28 pmRNSIssue of Equity
30th Aug 20194:29 pmRNSNet Asset Value(s)
27th Aug 20192:55 pmRNSTransaction in Own Shares
31st Jul 20192:16 pmRNSTransaction in Own Shares
18th Jul 20195:05 pmRNSHalf-year Report
4th Jul 20193:29 pmRNSStatement re Net Asset Value and Interim Dividend
5th Jun 20194:15 pmRNSDirectorate Change
14th May 20192:01 pmRNSTransaction in Own Shares
30th Apr 20191:06 pmRNSResult of AGM
24th Apr 20199:50 amRNSIssue of Equity
4th Apr 20192:16 pmRNSHolding(s) in Company
4th Apr 201911:01 amRNSIssue of Equity - Replacement
4th Apr 20199:17 amRNSIssue of Equity
25th Mar 20194:09 pmRNSStatement re Offer for Subscription
13th Mar 201912:12 pmRNSTransaction in Own Shares
7th Mar 20195:50 pmRNSIssue of Equity
4th Mar 201912:40 pmRNSNet Asset Value(s)
28th Feb 20195:42 pmRNSAnnual Financial Report
20th Feb 201912:30 pmRNSStatement re Offer for Subscription
15th Jan 20194:17 pmRNSTransaction in Own Shares
11th Jan 20193:50 pmRNSHolding(s) in Company
21st Dec 20181:00 pmRNSDirector/PDMR Shareholding
21st Dec 201810:39 amRNSIssue of Equity
18th Dec 20184:17 pmRNSNet Asset Value
5th Nov 20184:52 pmRNSTransaction in Own Shares
2nd Nov 201811:38 amRNSResult of General Meeting
10th Oct 20185:06 pmRNSTransaction in Own Shares
8th Oct 20184:48 pmRNSTransaction in Own Shares
5th Oct 20184:04 pmRNSTransaction in Own Shares
4th Oct 20183:03 pmRNSTransaction in Own Shares
3rd Oct 20187:00 amRNSNet Asset Value(s)
26th Sep 20186:29 pmRNSStatement re Offer for Subscription
24th Jul 20184:58 pmRNSTransaction in Own Shares
20th Jul 20182:56 pmRNSHalf-year Report
18th Jul 20189:21 amRNSNet Asset Value(s)
18th Jul 20187:00 amRNSStatement re Offer for Subscription
2nd May 20184:59 pmRNSHolding(s) in Company
25th Apr 20184:39 pmRNSNet Asset Value(s)
24th Apr 20181:34 pmRNSResult of AGM
12th Mar 20187:15 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.